Shionogi & Co., Ltd.

4507.T
Drug Manufacturers - Specialty & Generic
2026/10/29 11:49 Updated
Market Cap: $16.2B (¥2.6T)
Stock Price: $19.01 (¥3,003)
Exchange Rate: 1 USD = ¥157.98

Notice Regarding Revision (Increase) of Earnings Forecast and Annual Dividend Forecast for the Fiscal Year Ending March 2027

Revised upward the earnings forecast for the fiscal year ending March 2027 and increased the interim dividend to 40 yen, the year-end dividend to 46 yen, and the annual dividend to 86 yen. The dividend increase reflects the results of growth investments and a strengthened earnings base.

Importance:
Page Updated: October 29, 2026
IR Disclosure Date: October 29, 2026

Key Figures

  • Revenue: 720,000 million yen (vs. previous forecast +2.9%)
  • Operating Income: 230,000 million yen (vs. previous forecast +4.5%)
  • Profit Before Income Taxes: 220,500 million yen (vs. previous forecast +0.2%)

AI要約

Summary of Performance

Shionogi & Co., Ltd. has revised upward its consolidated full-year earnings forecast for the fiscal year ending March 2027. Revenue is expected to be 720,000 million yen, operating income 230,000 million yen, profit before income taxes 220,500 million yen, and net income attributable to owners of parent 212,500 million yen. The primary drivers are the tangible results of growth investments made in fiscal 2025 and contributions from strengthened ALS operations and the anti-infectives portfolio.

Dividend Policy and Rationale for the Increase

The interim dividend will be 40 yen, the year-end dividend 46 yen, and the annual dividend 86 yen (an increase of 15 yen from the previous year). The company maintains a stable dividend policy targeting a DOE of 4% or higher. Enhanced cash generation from the results of growth investments supports expanded shareholder returns. Specifics of capital policy will be re-presented in next year’s medium-term management plan.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Shionogi & Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →